KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 0.9.

  • Biolife Solutions' Equity Ratio rose 579.76% to 0.9 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.9, marking a year-over-year increase of 579.76%. This contributed to the annual value of 0.87 for FY2024, which is 675.18% up from last year.
  • As of Q3 2025, Biolife Solutions' Equity Ratio stood at 0.9, which was up 579.76% from 0.9 recorded in Q2 2025.
  • Biolife Solutions' 5-year Equity Ratio high stood at 0.9 for Q3 2025, and its period low was 0.8 during Q1 2023.
  • In the last 5 years, Biolife Solutions' Equity Ratio had a median value of 0.86 in 2021 and averaged 0.85.
  • Over the last 5 years, Biolife Solutions' Equity Ratio had its largest YoY gain of 2202.41% in 2021, and its largest YoY loss of 830.76% in 2021.
  • Biolife Solutions' Equity Ratio (Quarter) stood at 0.86 in 2021, then dropped by 6.21% to 0.81 in 2022, then increased by 1.14% to 0.82 in 2023, then grew by 6.75% to 0.87 in 2024, then rose by 3.3% to 0.9 in 2025.
  • Its last three reported values are 0.9 in Q3 2025, 0.9 for Q2 2025, and 0.89 during Q1 2025.